Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis (halobetasol)
This study is not yet open for participant recruitment.
Study NCT00715975   Information provided by L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
First Received: July 11, 2008   Last Updated: July 14, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
halobetasol
clobetasol
More general drug interventions related to this trial
Anti-Inflammatory Agents
Cardiovascular Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services